Celularity Inc. Revenue Breakdown
No Revenue Breakdown for CELU on this site yet.
- 2025-12-31: Others Not split by product in the filing$26.55M100.00%; Total revenue $26.55M.
- 2024-12-31: Others Not split by product in the filing$54.22M100.00%; Total revenue $54.22M.
- 2023-12-31: Others Not split by product in the filing$22.77M100.00%; Total revenue $22.77M.
- 2022-12-31: Others Not split by product in the filing$17.98M100.00%; Total revenue $17.98M.
Source checked: the stored Revenue Breakdown page for CELU.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $26.55M 100.00% | $26.55M |
| 2024-12-31 | Not split by product in the filing $54.22M 100.00% | $54.22M |
| 2023-12-31 | Not split by product in the filing $22.77M 100.00% | $22.77M |
| 2022-12-31 | Not split by product in the filing $17.98M 100.00% | $17.98M |
| 2021-12-31 | Not split by product in the filing $21.34M 100.00% | $21.34M |
| 2020-12-31 | Not split by product in the filing $14.28M 100.00% | $14.28M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product $4.10M 100.00% | $4.10M |
| 2025-09-30 | Not split by product $5.28M 100.00% | $5.28M |
| 2025-06-30 | Not split by product $5.74M 100.00% | $5.74M |
| 2025-03-31 | Not split by product $11.43M 100.00% | $11.43M |
| 2024-12-31 | Not split by product $18.13M 100.00% | $18.13M |
| 2024-09-30 | Not split by product $9.30M 100.00% | $9.30M |
| 2024-06-30 | Not split by product $12.11M 100.00% | $12.11M |
| 2024-03-31 | Not split by product $14.68M 100.00% | $14.68M |
| 2023-12-31 | Not split by product $12.11M 100.00% | $12.11M |
| 2023-09-30 | Not split by product $3.79M 100.00% | $3.79M |
| 2023-06-30 | Not split by product $2.94M 100.00% | $2.94M |
| 2023-03-31 | Not split by product $3.94M 100.00% | $3.94M |
| 2022-12-31 | Not split by product $4.13M 100.00% | $4.13M |
| 2022-09-30 | Not split by product $4.13M 100.00% | $4.13M |
| 2022-06-30 | Not split by product $3.78M 100.00% | $3.78M |
| 2022-03-31 | Not split by product $5.93M 100.00% | $5.93M |
| 2021-12-31 | Not split by product $4.86M 100.00% | $4.86M |
| 2021-09-30 | Not split by product $10.62M 100.00% | $10.62M |
| 2021-06-30 | Not split by product $3.20M 100.00% | $3.20M |
| 2021-03-31 | Not split by product $2.66M 100.00% | $2.66M |
| 2020-12-31 | Not split by product $3.24M 100.00% | $3.24M |
| 2020-09-30 | Not split by product $3.35M 100.00% | $3.35M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |